These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
177 related items for PubMed ID: 11472419
1. De-novo humoral immune responses to cancer-associated autoantigens during transition from chronic liver disease to hepatocellular carcinoma. Zhang JY, Zhu W, Imai H, Kiyosawa K, Chan EK, Tan EM. Clin Exp Immunol; 2001 Jul; 125(1):3-9. PubMed ID: 11472419 [Abstract] [Full Text] [Related]
2. Autoantibodies to IGF-II mRNA binding protein p62 and overexpression of p62 in human hepatocellular carcinoma. Zhang J, Chan EK. Autoimmun Rev; 2002 May; 1(3):146-53. PubMed ID: 12849008 [Abstract] [Full Text] [Related]
12. Humoral autoimmune response to nucleophosmin in the immunodiagnosis of hepatocellular carcinoma. Liu M, Varela-Ramirez A, Li J, Dai L, Aguilera RJ, Zhang JY. Oncol Rep; 2015 May; 33(5):2245-52. PubMed ID: 25779011 [Abstract] [Full Text] [Related]
13. Nuclear antigens reacted with sera and ascites of hepatocellular carcinoma patients. Chen YM, Hu CP, Chen PH, Chu MH, Tsai YT, Lee SD, Chang CM. Hepatology; 1988 May; 8(3):547-52. PubMed ID: 2836290 [Abstract] [Full Text] [Related]
14. Immunogenicity of Ra1A and its tissue-specific expression in hepatocellular carcinoma. Wang K, Chen Y, Liu S, Qiu S, Gao S, Huang X, Zhang J, Peng X, Qiani W, Zhang JY. Int J Immunopathol Pharmacol; 2009 May; 22(3):735-43. PubMed ID: 19822090 [Abstract] [Full Text] [Related]
15. Squamous cell carcinoma antigen-IgM is associated with hepatocellular carcinoma in patients with cirrhosis: A prospective study. Biasiolo A, Trotta E, Fasolato S, Ruvoletto M, Martini A, Gallotta A, Fassina G, Angeli P, Gatta A, Pontisso P. Dig Liver Dis; 2016 Feb; 48(2):197-202. PubMed ID: 26614642 [Abstract] [Full Text] [Related]
16. Serum anti-osteopontin autoantibody as a novel diagnostic and prognostic biomarker in patients with hepatocellular carcinoma. Ying X, Zhao Y, Wang JL, Zhou X, Zhao J, He CC, Guo XJ, Jin GH, Wang LJ, Zhu Q, Han SX. Oncol Rep; 2014 Oct; 32(4):1550-6. PubMed ID: 25109745 [Abstract] [Full Text] [Related]
17. Expression of insulin-like growth factor II in chronic hepatitis B, liver cirrhosis, and hepatocellular carcinoma. Seo JH, Park BC. Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():292-307. PubMed ID: 7661600 [Abstract] [Full Text] [Related]
18. Fine specificity mapping of autoantigens targeted by anti-centromere autoantibodies. Akbarali Y, Matousek-Ronck J, Hunt L, Staudt L, Reichlin M, Guthridge JM, James JA. J Autoimmun; 2006 Dec; 27(4):272-80. PubMed ID: 17210244 [Abstract] [Full Text] [Related]
19. Autoantibodies to Golgi proteins in hepatocellular carcinoma: case report and literature review. Mozo L, Simó A, Suárez A, Rodrigo L, Gutiérrez C. Eur J Gastroenterol Hepatol; 2002 Jul; 14(7):771-4. PubMed ID: 12169987 [Abstract] [Full Text] [Related]
20. High frequency of neoplasia in patients with autoantibodies to centromere protein CENP-F. Rattner JB, Rees J, Whitehead CM, Casiano CA, Tan EM, Humbel RL, Conrad K, Fritzler MJ. Clin Invest Med; 1997 Oct; 20(5):308-19. PubMed ID: 9336656 [Abstract] [Full Text] [Related] Page: [Next] [New Search]